Regulation of T Cell Signaling: Structural Studies of PLCgamma1
T 细胞信号传导的调节:PLCgamma1 的结构研究
基本信息
- 批准号:7615554
- 负责人:
- 金额:$ 32.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-05-01 至 2013-04-30
- 项目状态:已结题
- 来源:
- 关键词:1,2-diacylglycerolActive SitesAdoptedAreaAttenuatedAutoimmunityBindingBiochemicalBiologicalBiological AssayBiological ModelsCatalytic DomainCell Surface ReceptorsCellsChemistryCollaborationsComplexCytoskeletonDataDiglyceridesDiseaseDockingEnzymesEventFaceFamilyGoalsHydrolysisImmune System DiseasesImmune responseImmunosuppressionInositolKnowledgeLaboratoriesLeadLengthLigandsLiteratureMEKsMature T-LymphocyteMediatingMolecularMolecular ConformationMutationNMR SpectroscopyNaturePathway interactionsPhosphatidylinositol 4,5-DiphosphatePhosphatidylinositolsPhospholipasePhospholipase CPhosphorylationPhosphotransferasesPhosphotyrosineProtein IsoformsRas/RafReceptor Protein-Tyrosine KinasesRegulationReportingResearchRoleSecond Messenger SystemsSignal PathwaySignal TransductionSignaling ProteinSiteSpecificityStructureT-Cell ReceptorT-LymphocyteTestingTherapeutic InterventionTyrosine PhosphorylationWorkbasedesignenzyme substrate complexextracellularfeedingimmune functioninhibitor/antagonistinnovationinsightinterestloss of function mutationmouse modelnovelpreventprofessorprogramsprotein protein interactionpublic health relevancereceptorrelease of sequestered calcium ion into cytoplasmresponsesecond messengersrc Homology Domainsstructural biologytherapeutic targetthree dimensional structurethymocyte
项目摘要
DESCRIPTION (provided by applicant): In response to signal initiation at a number of different extracellular receptors, phospholipase C (PLC) hydrolyzes phosphatidyl inositol (4,5)bisphosphate (PIP2) to inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). In turn, IP3 and DAG control calcium flux, PKC activation and activation of the Ras-Raf-MEK-ERK pathway. In spite of the importance of the PLC enzymes, there is a significant gap in our knowledge regarding the molecular determinants that control PLC function. The two aims in this revsed application focus on the regulation of a single isoform of the phospholipases, PLC?1, in the context of signaling downstream of the T cell receptor. The PLC?1 isoform contains a number of Src homolgy domains that have been implicated in regulation of PLC?1 activity. The precise mechanism of regulation is not known. In our preliminary data we present a number of new findings that provide exciting insights into how the Src homolgy 2 (SH2) domains of PLC?1 function to control phospholipase activity. Following T cell receptor stimulation, PLC?1 is phosphorylated by the Tec family kinase Itk. We describe an unprecedented substrate docking mechanism that involves a direct interaction between the kinase domain of Itk and the carboxy-terminal SH2 domain of PLC?1. This protein-protein interaction is required for phosphorylation of Y783 in PLC?1 by Itk. Quite interesting is the fact that the interaction occurs in a phosphotyrosine-independent fashion; not the expected result for an SH2 mediated binding event. Further preliminary data show another noncanonical SH2 interaction whithin PLC?1 that inhibits the substrate docking interaction with Itk. The structural details of these regulatory complexes will be elucidated during the course of the proposed work and the results transferred into functional assays to develop a molecular level understanding of PLC?1 function. Given the non-canonical nature of the observed SH2 mediated interactions we expect that completion of the proposed aims will be particularly useful in properly dissecting the role of PLC?1 in T cell signaling. To date, biochemical and cell biological probes into the role of the SH2 domains in controlling PLC?1 mediated signaling have been limited to traditional 'loss-of-funtion' mutations that only disrupt canonical phosphotyrosine recognition. PUBLIC HEALTH RELEVANCE This proposal aims to understand specific molecular events leading to activation of the immune response. The molecules that will be studied are prime therapeutic targets for modulating an immune response in the context of disease. Thus, the public health relevance of the project relates to developing new ways to either limit or enhance the immune response in the face of autoimmunity, immunosuppression or immunological diseases.
描述(由申请人提供):响应于许多不同细胞外受体处的信号起始,磷脂酶 C (PLC) 将磷脂酰肌醇 (4,5) 二磷酸 (PIP2) 水解为肌醇 1,4,5-三磷酸 (IP3) 和二酰基甘油 (DAG)。反过来,IP3 和 DAG 控制钙通量、PKC 激活和 Ras-Raf-MEK-ERK 通路的激活。尽管 PLC 酶很重要,但我们对控制 PLC 功能的分子决定因素的了解还存在很大差距。此修订后的应用程序的两个目标集中于在 T 细胞受体下游信号传导的背景下调节磷脂酶的单一异构体 PLC?1。 PLC?1 同工型包含许多与 PLC?1 活性调节有关的 Src 同源结构域。确切的调节机制尚不清楚。在我们的初步数据中,我们提出了许多新发现,这些发现为了解 PLC?1 的 Src 同源 2 (SH2) 结构域如何发挥控制磷脂酶活性的作用提供了令人兴奋的见解。 T 细胞受体刺激后,PLC?1 被 Tec 家族激酶 Itk 磷酸化。我们描述了一种前所未有的底物对接机制,该机制涉及 Itk 的激酶结构域和 PLC?1 的羧基末端 SH2 结构域之间的直接相互作用。这种蛋白质-蛋白质相互作用是 Itk 磷酸化 PLC?1 中 Y783 所必需的。非常有趣的是,这种相互作用以不依赖于磷酸酪氨酸的方式发生。不是 SH2 介导的结合事件的预期结果。进一步的初步数据显示了 PLC?1 中的另一种非规范 SH2 相互作用,它抑制了与 Itk 的底物对接相互作用。这些调节复合物的结构细节将在拟议的工作过程中得到阐明,并将结果转化为功能测定,以发展对 PLC?1 功能的分子水平理解。鉴于所观察到的 SH2 介导的相互作用的非规范性质,我们预计完成所提出的目标对于正确剖析 PLC?1 在 T 细胞信号传导中的作用将特别有用。迄今为止,对 SH2 结构域在控制 PLC?1 介导的信号传导中的作用的生化和细胞生物学探针仅限于传统的“功能丧失”突变,这些突变只会破坏典型的磷酸酪氨酸识别。公共卫生相关性 该提案旨在了解导致免疫反应激活的特定分子事件。将研究的分子是在疾病背景下调节免疫反应的主要治疗靶点。因此,该项目的公共卫生相关性涉及开发新方法来限制或增强面对自身免疫、免疫抑制或免疫疾病时的免疫反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
AMY H ANDREOTTI其他文献
AMY H ANDREOTTI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('AMY H ANDREOTTI', 18)}}的其他基金
Console and Probe Upgrade for a 700 MHz NMR Spectrometer
700 MHz NMR 波谱仪的控制台和探头升级
- 批准号:
10415275 - 财政年份:2022
- 资助金额:
$ 32.56万 - 项目类别:
Molecularly imprinted nanoparticles as new tools to elucidate T cell signaling events
分子印迹纳米颗粒作为阐明 T 细胞信号传导事件的新工具
- 批准号:
10452166 - 财政年份:2022
- 资助金额:
$ 32.56万 - 项目类别:
Molecularly imprinted nanoparticles as new tools to elucidate T cell signaling events
分子印迹纳米颗粒作为阐明 T 细胞信号传导事件的新工具
- 批准号:
10559701 - 财政年份:2022
- 资助金额:
$ 32.56万 - 项目类别:
Screening for inhibitors of the T cell Tec kinase, ltk
筛选 T 细胞 Tec 激酶 ltk 抑制剂
- 批准号:
7993303 - 财政年份:2010
- 资助金额:
$ 32.56万 - 项目类别:
Regulation of T Cell Signaling: Structural Studies of PLCgamma1
T 细胞信号传导的调节:PLCgamma1 的结构研究
- 批准号:
8260866 - 财政年份:2008
- 资助金额:
$ 32.56万 - 项目类别:
Regulation of T Cell Signaling: Structural Studies of PLCgamma1
T 细胞信号传导的调节:PLCgamma1 的结构研究
- 批准号:
7803735 - 财政年份:2008
- 资助金额:
$ 32.56万 - 项目类别:
Regulation of T Cell Signaling: Structural Studies of PLCgamma1
T 细胞信号传导的调节:PLCgamma1 的结构研究
- 批准号:
8068838 - 财政年份:2008
- 资助金额:
$ 32.56万 - 项目类别:
Regulation of T Cell Signaling: Structural Studies of PLCgamma1
T 细胞信号传导的调节:PLCgamma1 的结构研究
- 批准号:
7469611 - 财政年份:2008
- 资助金额:
$ 32.56万 - 项目类别:
STRUCTURAL STUDIES OF A T CELL SPECIFIC TYROSINE KINASE
T 细胞特异性酪氨酸激酶的结构研究
- 批准号:
6137270 - 财政年份:1999
- 资助金额:
$ 32.56万 - 项目类别:
STRUCTURAL STUDIES OF A T CELL SPECIFIC TYROSINE KINASE
T 细胞特异性酪氨酸激酶的结构研究
- 批准号:
6488716 - 财政年份:1999
- 资助金额:
$ 32.56万 - 项目类别:
相似海外基金
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
- 批准号:
2334970 - 财政年份:2024
- 资助金额:
$ 32.56万 - 项目类别:
Standard Grant
NSF-BSF: Towards a Molecular Understanding of Dynamic Active Sites in Advanced Alkaline Water Oxidation Catalysts
NSF-BSF:高级碱性水氧化催化剂动态活性位点的分子理解
- 批准号:
2400195 - 财政年份:2024
- 资助金额:
$ 32.56万 - 项目类别:
Standard Grant
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
- 批准号:
2334969 - 财政年份:2024
- 资助金额:
$ 32.56万 - 项目类别:
Standard Grant
Mechanochemical synthesis of nanocarbon and design of active sites for oxygen reducton/evolution reactions
纳米碳的机械化学合成和氧还原/演化反应活性位点的设计
- 批准号:
23K04919 - 财政年份:2023
- 资助金额:
$ 32.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Creation of porous inorganic frameworks with controlled structure of metal active sites by the building block method.
通过积木法创建具有金属活性位点受控结构的多孔无机框架。
- 批准号:
22KJ2957 - 财政年份:2023
- 资助金额:
$ 32.56万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Catalysis of Juxaposed Active Sites Created in Nanospaces and Their Applications
纳米空间中并置活性位点的催化及其应用
- 批准号:
23K04494 - 财政年份:2023
- 资助金额:
$ 32.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Generation of carbon active sites by modifying the oxygen containing functional groups and structures of carbons for utilizing to various catalytic reactions.
通过修饰碳的含氧官能团和结构来产生碳活性位点,用于各种催化反应。
- 批准号:
23K13831 - 财政年份:2023
- 资助金额:
$ 32.56万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
CAREER: CAS: Understanding the Chemistry of Palladium and Silyl Compounds to Design Catalyst Active Sites
职业:CAS:了解钯和甲硅烷基化合物的化学性质以设计催化剂活性位点
- 批准号:
2238379 - 财政年份:2023
- 资助金额:
$ 32.56万 - 项目类别:
Continuing Grant
CAS: Collaborative Research: Tailoring the Distribution of Transient vs. Dynamic Active Sites in Solid-Acid Catalysts and Their Impacts on Chemical Conversions
CAS:合作研究:定制固体酸催化剂中瞬时活性位点与动态活性位点的分布及其对化学转化的影响
- 批准号:
2154399 - 财政年份:2022
- 资助金额:
$ 32.56万 - 项目类别:
Standard Grant
Engineering of Active Sites in Heterogeneous Catalysts for Sustainable Chemical and Fuel Production.
用于可持续化学和燃料生产的多相催化剂活性位点工程。
- 批准号:
RGPIN-2019-06633 - 财政年份:2022
- 资助金额:
$ 32.56万 - 项目类别:
Discovery Grants Program - Individual